A team of neurologists is conducting a randomized, double-blind crossover trial to compare the efficacy of two disease-modifying therapies (Drug X and Drug Y) in patients with relapsing-remitting multiple sclerosis. Fifty patients are enrolled and randomized to receive either Drug X or Drug Y for 12 months. After a 3-month washout period, the patients are switched to the alternative therapy for another 12 months. The primary outcome measure is the total volume of T2-hyperintense white matter lesions, measured in cubic millimeters () via brain magnetic resonance imaging (MRI) at the end of each 12-month treatment period. Preliminary data analysis confirms that the lesion volume measurements follow a normal distribution. Which of the following statistical tests is the most appropriate to compare the primary outcome between the two treatment periods?
- Paired t-testAnswer
- BTwo-sample t-test
- CWilcoxon signed-rank test
- DAnalysis of variance
- EMcNemar test